1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Epigenetics
  3. PARP
  4. TNKS1/PARP5A Isoform

TNKS1/PARP5A

 

TNKS1/PARP5A Related Products (24):

Cat. No. Product Name Effect Purity
  • HY-10162
    Olaparib
    Inhibitor 99.98%
    Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively.
  • HY-15147
    XAV-939
    Inhibitor 99.91%
    XAV-939 is a Tankyrase inhibitor.
  • HY-10619
    Niraparib
    Inhibitor 99.96%
    Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively.
  • HY-10619B
    Niraparib tosylate
    Inhibitor 99.97%
    Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively.
  • HY-12438
    G007-LK
    Inhibitor 99.42%
    G007-LK is a potent and selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively.
  • HY-148566
    OUL232
    Inhibitor
    OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15.
  • HY-152198
    Tankyrase-IN-4
    Inhibitor
    Tankyrase-IN-4 is a tankyrase 1 (TNKS1) inhibitor with an IC50 value of 0.8 nM.
  • HY-152197
    Tankyrase-IN-3
    Inhibitor
    Tankyrase-IN-3 is a tankyrase 1 (TNKS1) inhibitor with an IC50 value of 22 nM.
  • HY-10619A
    Niraparib hydrochloride
    Inhibitor 99.76%
    Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively.
  • HY-100225
    ME0328
    Inhibitor 99.87%
    ME0328 is a potent and selective ARTD3/PARP3 inhibitor with an IC50 of 0.89±0.28 μM.
  • HY-122661
    Mefuparib hydrochloride
    Inhibitor 98.94%
    Mefuparib hydrochloride (MPH) is an orally active, substrate-competitive and selective PARP1/2 inhibitor with IC50s of 3.2 nM and 1.9 nM, respectively.
  • HY-12418
    Stenoparib
    Inhibitor ≥98.0%
    E7449 is a potent PARP1 and PARP2 inhibitor and also inhibits TNKS1 and TNKS2, with IC50s of 2.0, 1.0, ∼50 and ∼50 nM for PARP1, PARP2, TNKS1 and TNKS2, respectively, using 32P-NAD+ as substrate.
  • HY-123892
    RK-287107
    Inhibitor 99.81%
    RK-287107 is a potent and specific tankyrase inhibitor with IC50s of 14.3 and 10.6 nM for tankyrase-1 and tankyrase-2, respectively.
  • HY-19351
    MN-64
    Inhibitor 99.73%
    MN-64 is a potent tankyrase 1 inhibitor, with IC50s of 6 nM, 72 nM, 19.1 μM, and 39.4 μM for TNKS1, TNKS2, ARTD1 and ARTD2, respectively.
  • HY-145267
    OM-153
    Inhibitor 99.59%
    OM-153 is a potent and orally active tankyrase inhibitor with IC50s of 13 nM and 2 nM for tankyrase 1 and tankyrase 2 (TNKS1/2), respectively.
  • HY-U00422
    K-756
    Inhibitor 99.76%
    K-756 is a direct and selective tankyrase (TNKS) inhibitor, which inhibits the ADP-ribosylation activity of TNKS1 and TNKS2 with IC50s of 31 and 36 nM, respectively.
  • HY-147886
    PARP1-IN-11
    Inhibitor 98.58%
    PARP1-IN-11 (compound 49) is a potent PARP1 inhibitor with IC50 value of 0.082 µM.
  • HY-10619E
    Niraparib tosylate hydrate
    Inhibitor
    Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively.
  • HY-145266
    OM-1700
    Inhibitor
    OM-1700 is a potent tankyrase inhibitor with IC50s of 127 and 14 nM for tankyrase 1 and tankyrase 2, respectively.
  • HY-108516
    TC-E 5001
    Inhibitor
    TC-E 5001 is an inhibitor of Wnt pathway that inhibits tankyrase 1/2 (TNKS1/2) via novel adenosine pocket binding, with Kds of 79 nM and 28 nM, respectively.